Karyopharm Therapeutics (KPTI) Files $200M Mixed Securities Shelf

November 8, 2016 8:56 AM EST

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Karyopharm Therapeutics (Nasdaq: KPTI) filed a registration with the U.S. SEC to sell up to $200 million of mixed securities.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment